151 related articles for article (PubMed ID: 16782335)
1. Benzimidazole-2-carboxamides as novel NR2B selective NMDA receptor antagonists.
Borza I; Kolok S; Gere A; Nagy J; Fodor L; Galgóczy K; Fetter J; Bertha F; Agai B; Horváth C; Farkas S; Domány G
Bioorg Med Chem Lett; 2006 Sep; 16(17):4638-40. PubMed ID: 16782335
[TBL] [Abstract][Full Text] [Related]
2. Kynurenic acid amides as novel NR2B selective NMDA receptor antagonists.
Borza I; Kolok S; Galgóczy K; Gere A; Horváth C; Farkas S; Greiner I; Domány G
Bioorg Med Chem Lett; 2007 Jan; 17(2):406-9. PubMed ID: 17074483
[TBL] [Abstract][Full Text] [Related]
3. Structure-activity relationship study of novel NR2B-selective antagonists with arylamides to avoid reactive metabolites formation.
Kawai M; Sakurada I; Morita A; Iwamuro Y; Ando K; Omura H; Sakakibara S; Masuda T; Koike H; Honma T; Hattori K; Takashima T; Mizuno K; Mizutani M; Kawamura M
Bioorg Med Chem Lett; 2007 Oct; 17(20):5537-42. PubMed ID: 17766107
[TBL] [Abstract][Full Text] [Related]
4. Indole-2-carboxamidines as novel NR2B selective NMDA receptor antagonists.
Borza I; Kolok S; Ignácz-Szendrei G; Greiner I; Tárkányi G; Galgóczy K; Horváth C; Farkas S; Domány G
Bioorg Med Chem Lett; 2005 Dec; 15(24):5439-41. PubMed ID: 16213709
[TBL] [Abstract][Full Text] [Related]
5. Selective NR1/2B N-methyl-D-aspartate receptor antagonists among indole-2-carboxamides and benzimidazole-2-carboxamides.
Borza I; Bozó E; Barta-Szalai G; Kiss C; Tárkányi G; Demeter A; Gáti T; Háda V; Kolok S; Gere A; Fodor L; Nagy J; Galgóczy K; Magdó I; Agai B; Fetter J; Bertha F; Keserü GM; Horváth C; Farkas S; Greiner I; Domány G
J Med Chem; 2007 Mar; 50(5):901-14. PubMed ID: 17290978
[TBL] [Abstract][Full Text] [Related]
6. Oxamides as novel NR2B selective NMDA receptor antagonists.
Barta-Szalai G; Borza I; Bozó E; Kiss C; Agai B; Proszenyák A; Keseru GM; Gere A; Kolok S; Galgóczy K; Horváth C; Farkas S; Domány G
Bioorg Med Chem Lett; 2004 Aug; 14(15):3953-6. PubMed ID: 15225705
[TBL] [Abstract][Full Text] [Related]
7. New benzoyl urea derivatives as novel NR2B selective NMDA receptor antagonists.
Borza I; Greiner I; Kolok S; Galgóczy K; Ignácz-Szendrei G; Horváth C; Farkas S; Gáti T; Háda V; Domány G
Pharmazie; 2006 Sep; 61(9):799-800. PubMed ID: 17020160
[TBL] [Abstract][Full Text] [Related]
8. Structure-activity relationship of N-(phenylalkyl)cinnamides as novel NR2B subtype-selective NMDA receptor antagonists.
Tamiz AP; Cai SX; Zhou ZL; Yuen PW; Schelkun RM; Whittemore ER; Weber E; Woodward RM; Keana JF
J Med Chem; 1999 Aug; 42(17):3412-20. PubMed ID: 10464027
[TBL] [Abstract][Full Text] [Related]
9. A novel series of benzimidazole NR2B-selective NMDA receptor antagonists.
Davies DJ; Crowe M; Lucas N; Quinn J; Miller DD; Pritchard S; Grose D; Bettini E; Calcinaghi N; Virginio C; Abberley L; Goldsmith P; Michel AD; Chessell IP; Kew JN; Miller ND; Gunthorpe MJ
Bioorg Med Chem Lett; 2012 Apr; 22(7):2620-3. PubMed ID: 22366657
[TBL] [Abstract][Full Text] [Related]
10. Discovery of novel and orally active NR2B-selective N-methyl-D-aspartate (NMDA) antagonists, pyridinol derivatives with reduced HERG binding affinity.
Kawai M; Nakamura H; Sakurada I; Shimokawa H; Tanaka H; Matsumizu M; Ando K; Hattori K; Ohta A; Nukui S; Omura A; Kawamura M
Bioorg Med Chem Lett; 2007 Oct; 17(20):5533-6. PubMed ID: 17768047
[TBL] [Abstract][Full Text] [Related]
11. NR2B-selective N-methyl-D-aspartate antagonists: synthesis and evaluation of 5-substituted benzimidazoles.
McCauley JA; Theberge CR; Romano JJ; Billings SB; Anderson KD; Claremon DA; Freidinger RM; Bednar RA; Mosser SD; Gaul SL; Connolly TM; Condra CL; Xia M; Cunningham ME; Bednar B; Stump GL; Lynch JJ; Macaulay A; Wafford KA; Koblan KS; Liverton NJ
J Med Chem; 2004 Apr; 47(8):2089-96. PubMed ID: 15056006
[TBL] [Abstract][Full Text] [Related]
12. The search for novel TRPV1-antagonists: from carboxamides to benzimidazoles and indazolones.
Fletcher SR; McIver E; Lewis S; Burkamp F; Leech C; Mason G; Boyce S; Morrison D; Richards G; Sutton K; Jones AB
Bioorg Med Chem Lett; 2006 Jun; 16(11):2872-6. PubMed ID: 16563760
[TBL] [Abstract][Full Text] [Related]
13. Design, Synthesis, and Biological Evaluation of 3-Benzazepin-1-ols as NR2B-Selective NMDA Receptor Antagonists.
Tewes B; Frehland B; Schepmann D; Schmidtke KU; Winckler T; Wünsch B
ChemMedChem; 2010 May; 5(5):687-95. PubMed ID: 20340125
[TBL] [Abstract][Full Text] [Related]
14. Identification of a novel NR2B-selective NMDA receptor antagonist using a virtual screening approach.
Mony L; Triballeau N; Paoletti P; Acher FC; Bertrand HO
Bioorg Med Chem Lett; 2010 Sep; 20(18):5552-8. PubMed ID: 20692832
[TBL] [Abstract][Full Text] [Related]
15. Indole-2-carboxamides as novel NR2B selective NMDA receptor antagonists.
Borza I; Kolok S; Gere A; Agai-Csongor E; Agai B; Tárkányi G; Horváth C; Barta-Szalai G; Bozó E; Kiss C; Bielik A; Nagy J; Farkas S; Domány G
Bioorg Med Chem Lett; 2003 Nov; 13(21):3859-61. PubMed ID: 14552795
[TBL] [Abstract][Full Text] [Related]
16. Conformationally constrained NR2B selective NMDA receptor antagonists derived from ifenprodil: Synthesis and biological evaluation of tetrahydro-3-benzazepine-1,7-diols.
Tewes B; Frehland B; Schepmann D; Schmidtke KU; Winckler T; Wünsch B
Bioorg Med Chem; 2010 Nov; 18(22):8005-15. PubMed ID: 20965739
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and evaluation of novel tricyclic benzo[4.5]cyclohepta[1.2]pyridine derivatives as NMDA/NR2B antagonists.
McIntyre CJ; McCauley JA; Bednar B; Bednar RA; Butcher JW; Claremon DA; Cunningham ME; Freidinger RM; Gaul SL; Homnick CF; Koblan KS; Mosser SD; Romano JJ; Liverton NJ
Bioorg Med Chem Lett; 2009 Sep; 19(17):5132-5. PubMed ID: 19648007
[TBL] [Abstract][Full Text] [Related]
18. Novel non-steroidal/non-anilide type androgen antagonists: discovery of 4-substituted pyrrole-2-carboxamides as a new scaffold for androgen receptor ligands.
Wakabayashi K; Miyachi H; Hashimoto Y; Tanatani A
Bioorg Med Chem; 2005 Apr; 13(8):2837-46. PubMed ID: 15781394
[TBL] [Abstract][Full Text] [Related]
19. Syntheses and structure-activity relationships of novel, potent, and selective trans-2-[3-oxospiro[isobenzofuran-1(3H),1'-cyclohexan]-4'-yl]benzimidazole NPY Y5 receptor antagonists.
Ogino Y; Ohtake N; Nagae Y; Matsuda K; Ishikawa M; Moriya M; Kanesaka M; Mitobe Y; Ito J; Kanno T; Ishihara A; Iwaasa H; Ohe T; Kanatani A; Fukami T
Bioorg Med Chem Lett; 2008 Sep; 18(18):4997-5001. PubMed ID: 18752943
[TBL] [Abstract][Full Text] [Related]
20. Cyclic benzamidines as orally efficacious NR2B-selective NMDA receptor antagonists.
Nguyen KT; Claiborne CF; McCauley JA; Libby BE; Claremon DA; Bednar RA; Mosser SD; Gaul SL; Connolly TM; Condra CL; Bednar B; Stump GL; Lynch JJ; Koblan KS; Liverton NJ
Bioorg Med Chem Lett; 2007 Jul; 17(14):3997-4000. PubMed ID: 17498948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
